SG11201810847RA - Non-invasive diagnostic imaging agent for heart disease - Google Patents
Non-invasive diagnostic imaging agent for heart diseaseInfo
- Publication number
- SG11201810847RA SG11201810847RA SG11201810847RA SG11201810847RA SG11201810847RA SG 11201810847R A SG11201810847R A SG 11201810847RA SG 11201810847R A SG11201810847R A SG 11201810847RA SG 11201810847R A SG11201810847R A SG 11201810847RA SG 11201810847R A SG11201810847R A SG 11201810847RA
- Authority
- SG
- Singapore
- Prior art keywords
- heart disease
- imaging agent
- diagnostic imaging
- invasive diagnostic
- invasive
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0453—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016115806 | 2016-06-10 | ||
| PCT/JP2017/021442 WO2017213247A1 (ja) | 2016-06-10 | 2017-06-09 | 心疾患の非侵襲的画像診断剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201810847RA true SG11201810847RA (en) | 2019-01-30 |
Family
ID=60577959
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201810847RA SG11201810847RA (en) | 2016-06-10 | 2017-06-09 | Non-invasive diagnostic imaging agent for heart disease |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20190255199A1 (de) |
| EP (1) | EP3470091A4 (de) |
| JP (1) | JPWO2017213247A1 (de) |
| KR (1) | KR20190016971A (de) |
| CN (1) | CN109310787A (de) |
| AU (1) | AU2017278446A1 (de) |
| CA (1) | CA3026617A1 (de) |
| SG (1) | SG11201810847RA (de) |
| WO (1) | WO2017213247A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019131458A1 (ja) * | 2017-12-28 | 2019-07-04 | 日本メジフィジックス株式会社 | ２－［５－（イミダゾール－１－イルメチル）ピリジン－３－イル］ベンズイミダゾール誘導体化合物、及び、これを含む医薬 |
| JP2021130610A (ja) * | 2018-05-08 | 2021-09-09 | 日本メジフィジックス株式会社 | 心疾患の非侵襲的画像診断剤 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR066691A1 (es) * | 2007-03-29 | 2009-09-09 | Speedel Experimenta Ag | Compuestos espiro heterociclicos derivados de imidazol. composiciones farmaceuticas. |
| JP5196561B2 (ja) * | 2007-11-07 | 2013-05-15 | 独立行政法人放射線医学総合研究所 | 核医学診断用医薬 |
| DE102008022221A1 (de) | 2008-05-06 | 2009-11-12 | Universität des Saarlandes | Inhibitoren der humanen Aldosteronsynthase CYP11B2 |
| ES2472446T3 (es) * | 2009-11-30 | 2014-07-01 | Novartis Ag | Derivados de imidazol como inhibidores de aldosterona sintasa |
| EP2394668A1 (de) | 2010-06-01 | 2011-12-14 | Julius-Maximilians-Universität Würzburg | PET-Radiopharmaka für die Differentialdiagnose zwischen bilateralen und unilateralen Bedingungen von primärem Hyperaldosteronismus |
| US9353081B2 (en) | 2011-09-23 | 2016-05-31 | Hoffmann-La Roche Inc. | Bicyclic dihydroquinoline-2-one derivatives |
| JP6048958B2 (ja) | 2012-12-27 | 2016-12-21 | 日本メジフィジックス株式会社 | 副腎疾患の画像診断剤 |
| JP2015093831A (ja) | 2013-11-08 | 2015-05-18 | 日本メジフィジックス株式会社 | アルドステロン合成酵素阻害剤 |
| JP2015093832A (ja) | 2013-11-08 | 2015-05-18 | 日本メジフィジックス株式会社 | 放射性ハロゲン標識化合物又はその塩、これを含む医薬 |
| JP2015110563A (ja) | 2013-11-08 | 2015-06-18 | 日本メジフィジックス株式会社 | アルドステロン合成酵素阻害剤 |
| JP2015093833A (ja) | 2013-11-08 | 2015-05-18 | 日本メジフィジックス株式会社 | 放射性ハロゲン標識化合物又はその塩、これを含む医薬 |
| JP2015193545A (ja) | 2014-03-31 | 2015-11-05 | 国立大学法人京都大学 | ２−（３−ピリジニル）−１ｈ−ベンズイミダゾール誘導体化合物、これを含む放射性医薬 |
| JP6313098B2 (ja) | 2014-04-04 | 2018-04-18 | イーデーエム株式会社 | サーマルプリンタ |
| MX2016017405A (es) * | 2014-06-26 | 2017-08-24 | Nihon Mediphysics Co Ltd | Compuestos derivados de 2-(3-piridinil)-1h-benzimidazol y medicamentos que los contienen. |
-
2017
- 2017-06-09 KR KR1020187036667A patent/KR20190016971A/ko unknown
- 2017-06-09 SG SG11201810847RA patent/SG11201810847RA/en unknown
- 2017-06-09 JP JP2018521787A patent/JPWO2017213247A1/ja active Pending
- 2017-06-09 AU AU2017278446A patent/AU2017278446A1/en not_active Abandoned
- 2017-06-09 WO PCT/JP2017/021442 patent/WO2017213247A1/ja unknown
- 2017-06-09 CN CN201780035800.9A patent/CN109310787A/zh active Pending
- 2017-06-09 US US16/308,014 patent/US20190255199A1/en not_active Abandoned
- 2017-06-09 CA CA3026617A patent/CA3026617A1/en not_active Abandoned
- 2017-06-09 EP EP17810420.4A patent/EP3470091A4/de not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CN109310787A (zh) | 2019-02-05 |
| EP3470091A4 (de) | 2019-06-19 |
| EP3470091A1 (de) | 2019-04-17 |
| CA3026617A1 (en) | 2017-12-14 |
| AU2017278446A1 (en) | 2018-12-20 |
| JPWO2017213247A1 (ja) | 2019-04-04 |
| US20190255199A1 (en) | 2019-08-22 |
| WO2017213247A1 (ja) | 2017-12-14 |
| KR20190016971A (ko) | 2019-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2015134464A3 (en) | Targeted therapeutics | |
| EP3563368A4 (de) | Herzsimulationssystem für medizinische dienste oder diagnosemaschinen | |
| MA34057B1 (fr) | Compositions et methodes pour le diagnostic et le traitement d'une tumeur | |
| MX2022002401A (es) | Productos radiofarmaceuticos, agentes de radioimagenologia,y uso de los mismos. | |
| GEP20237479B (en) | Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer | |
| PH12015501744B1 (en) | Therapeutic and diagnostic target for cancer comprising dll3 binding reagents | |
| JP2014221779A5 (de) | ||
| EP3466416A3 (de) | Bindungs-wirkstoff-konjugat, umfassend eine hsp90-bindungsgruppierung und eine zytotoxische effektorgruppierung | |
| MX2015005948A (es) | Polipeptidos para transporte de barrera hematoencefalica. | |
| WO2015171558A3 (en) | BENZENESULFONAMIDO AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORγ AND THE TREATEMENT OF DISEASE | |
| CN107406464A8 (zh) | 精氨酸酶抑制剂及其治疗用途 | |
| WO2015066053A3 (en) | Targeted therapeutics | |
| WO2017062468A8 (en) | Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof | |
| MX2015012528A (es) | Inhibidores macrociclicos de cinasa inducibles por sal. | |
| PH12020500354A1 (en) | Non-invasive diagnostic of non-alcoholic fatty liver diseases, non-alcoholic steatohepatitis and/or liver fibrosis | |
| EP3088898A4 (de) | Verfahren zur diagnose von morbus alzheimer und frontotemporaler lobärer degeneration, diagnosemittel, therapeutisches mittel und screening-verfahren für die besagten mittel | |
| EA201890221A1 (ru) | Hbed-бисфосфонаты, их конъюгаты с радиометаллом и их применение в качестве лечебно-диагностических агентов | |
| EP3375787A4 (de) | Peptidthioharnstoffderivat, radioisotopenmarkierte verbindung damit und pharmazeutische zusammensetzung damit als wirkstoff zur behandlung oder diagnose von prostatakrebs | |
| WO2017105565A3 (en) | Compositions for therapeutics, targeted pet imaging and methods of their use | |
| EP2410336A4 (de) | Diagnostischer marker für brustkrebs mit thioredoxin-1 als wirkstoff sowie diagnostisches kit damit für brustkrebs | |
| MX2015012526A (es) | Inhibodores macrociclicos de cinasa rip2. | |
| SG11201810847RA (en) | Non-invasive diagnostic imaging agent for heart disease | |
| WO2015062726A3 (en) | Hcbi sequences as an early marker for the future development of cancer and diseases of the cns and as a target for cancer treatment and prevention | |
| EP3741105A4 (de) | Dentale bilderzeugung ohne ionisierende strahlung durch nahinfrarot-fluoreszenz und verwandte systeme | |
| IL263047B (en) | Cryogenic tester for heart surgery |